Full Schedule

Home
Full Schedule

All Days
Wed, Oct 16
Thu, Oct 17
Fri, Oct 18

Full Schedule

Type here to filter the list

Thursday, October 17, 2024
7:30 AM – 8:30 AM ET
Continental Breakfast

7:30 AM – 8:30 AM ET

Continental Breakfast

7:30 AM – 5:30 PM ET
ASAM Registration Open

7:30 AM – 5:30 PM ET

ASAM Registration Open

8:30 AM – 8:45 AM ET
Welcome, Introductions and Opening Remarks

8:30 AM – 8:45 AM ET

Welcome, Introductions and Opening Remarks

Chair: Michael I. Fingerhood, MD, DFASAM (he/him/his) – Johns Hopkins University

8:45 AM – 10:30 AM ET
Initiation & Discontinuation

8:45 AM – 8:50 AM ET

Session Introduction

8:50 AM – 9:10 AM ET

Overcoming challenges to initiation of extended-release naltrexone for treating opioid use disorder – Findings from HEAL-Initiative NIDA Clinical Trials Network trial: Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT)

Presenter: Adam M. Bisaga, MD (he/him/his) – Columbia University College of Physicians and Surgeons

9:10 AM – 9:30 AM ET

Shared decision-making and rapid initiation of injection naltrexone for opioid use disorder: Practical tools from the SWIFT trial

Presenter: Edward V. Nunes, Jr., MD (he/him/his) – Columbia University Irving Medical Center

9:30 AM – 9:50 AM ET

Implementation considerations for emergency-department (ED)-based buprenorphine induction for opioid use disorder

Presenter: Kathryn F. Hawk, MD, MHS (she/her/hers) – Yale University

9:50 AM – 10:10 AM ET

Heterogeneous phenotypes for patients with opioid use disorder presenting to the emergency department: Implications for MOUD initiation

Presenter: R. Andrew Taylor, MD, MHS – Yale University

10:10 AM – 10:30 AM ET

Session Panel

10:30 AM – 10:45 AM ET
Refreshment Break

10:30 AM – 10:45 AM ET

Refreshment Break

10:45 AM – 12:30 PM ET
Comorbidities

10:45 AM – 10:50 AM ET

Session Introduction

10:50 AM – 11:10 AM ET

Early Liver Transplantation for Severe Alcoholic Hepatitis

Presenter: Robert M. Weinrieb, MD (he/him/his) – University of Pennsylvania, Perelman School of Medicine

11:10 AM – 11:30 AM ET

Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes

Presenter: Ju Park, PhD, MHS (she/her/hers) – Harm Reduction Innovation Lab, Rhode Island Hospital

11:30 AM – 11:50 AM ET

HIV & Addiction: Long-Acting Injectable Therapy for People with HIV

Presenter: Jessica A. Meisner, MD, MS, MSHP (she/her/hers) – Prevention Point Philadelphia

11:50 AM – 12:10 PM ET

The PROUD Study - Promoting Resilience for Medicaid Members with Opioid Use Disorder During Climate and Environmental Stressors

Presenter: Benjamin F. Springgate, MD, MPH, FACP (he/him/his) – LSU School of Medicine - New Orleans

12:10 PM – 12:30 PM ET

Session Panel

12:30 PM – 1:30 PM ET
Lunch Break

12:30 PM – 1:30 PM ET

Lunch Break

1:30 PM – 3:15 PM ET
Maintaining Recovery

1:30 PM – 1:35 PM ET

Session Introduction

1:35 PM – 1:55 PM ET

A Contextual Model of Addiction Recovery

Presenter: Samuel F. Acuff, PhD (he/him/his) – Recovery Research Institute, Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital

1:55 PM – 2:15 PM ET

Contingency Management

Presenter: Pamela A. Matson, PhD, MPH (she/her/hers) – Johns Hopkins University School of Medicine

2:15 PM – 2:35 PM ET

Expanding Methadone Access Across New York State

Presenter: Chinazo O. Cunningham, MD, MS (she/her/hers) – New York State Office of Addiction Services and Support

2:35 PM – 2:55 PM ET

Imani Breakthrough Program: A Culturally-Attuned, Faith-Based Opioid Recovery Intervention for Black and LatinX Communities

Presenter: Chyrell D. Bellamy, MSW, PhD (she/her/hers) – Yale School

2:55 PM – 3:15 PM ET

Session Panel

3:15 PM – 3:45 PM ET
Refreshment Break

3:15 PM – 3:45 PM ET

Refreshment Break

3:45 PM – 5:30 PM ET
Innovations in Technology

3:45 PM – 3:50 PM ET

Session Introduction

3:50 PM – 4:10 PM ET

Emerging Digital Therapeutic Treatments for Substance Use Disorders

Presenter: Lisa A. Marsch, PhD – Center for Technology and Behavioral Health; Geisel School of Medicine at Dartmouth College

4:10 PM – 4:30 PM ET

Tele-Harm Reduction

Presenter: Teresa A. Chueng, MD, MPH (she/her/hers) – University of Miami Miller School of Medicine

4:30 PM – 4:50 PM ET

10 Hz Excited DLPFC, but Not 1 Hz Inhibited mOFC Reduced Cigarette Consumption: A Randomized Repetitive Transcranial Magnetic Stimulation Trial

Presenter: Xingbao Li, MD – Medical University of South Carolina

4:50 PM – 5:10 PM ET

Primary and Secondary Findings from the NIDA CTN ADAPT-2 Trial in Relation to the Treatment of Methamphetamine Use Disorder

Presenter: Madhukar H. Trivedi, MD (he/him/his) – University of Texas Medical Center

5:10 PM – 5:30 PM ET

Session Panel

8:00 PM – 9:00 PM ET
Mutual Help (Open Meeting)

8:00 PM – 9:00 PM ET

Mutual Help (Open Meeting)